Nanoprecipitation for controlled formation of rasagaline mesylate (RM) microparticle agents
Nanoprecipitation for controlled formation of rasagaline mesylate (RM) microparticle agents
批准号:
580548-2022
负责人:
Zhang, XuehuaXH
金额:
$2.19万
依托单位:
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Parkinson's disease is a neurodegeneration disorder, affecting 1 in every 500 people in Canada. Rasagiline mesylate (RM) is a drug for treatment of Parkinson's disease. As a hydrophilic compound, RM has a short elimination half-life. Currently the clinical applications of RM for Parkinson's disease treatment are limited by its low bioavailability and the requirement of daily administrations. The quick and 'burst' release profiles of RM make it challenging for drug delivery systems. Through the partnership with Hermay Labs Corporation, the overall goal of the project is to develop a technology for producing RM microparticle agents used in control release systems. The project will employ a nanoprecipitation-based approach for producing RM microparticle agents by using an antisolvent. The physicochemical characteristics (size distribution, loading and encapsulation efficiency) of the agents will be controlled by both mixture composition and mixing dynamics of the antisolvent. The solubility diagrams of multiple components will be constructed to guide the selection of composition ratios. A novel 2D mixing device will be used to determine the composition for desirable properties of the particles. The formation of RM particle agents will be induced in a wide range of mixing rate of the RM solution and the antisolvent with presence of carrier materials to tune the release profile of the RM agents. The potential outcomes of the project will be (1) effective protocols for producing RM microparticle agents by nanoprecipitation; (2) correlations between mixing conditions and the characteristics of RM microparticles; (3) improved understanding of nanoprecipitation for hydrophilic compound in general for clinic medications; (4) Patents, presentations in conferences, and publications in peer-viewed journals. Four HQPs will be trained on this 2-year project. The research activities supported by NSERC is crucial for success and long-term impact of the project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Micro/Nanobubble-Enhanced Cold Plasma Activation of Water
-
批准号:571340-2021
-
项目类别:Alliance Grants
-
资助金额:$2.19万
-
财政年份:2022
-
负责人:Zhang, XuehuaXH
-
依托单位:
Computational fluid dynamics (CFD) simulations of tailings flow in pipelines for enhanced bitumen recovery
-
批准号:561533-2021
-
项目类别:Alliance Grants
-
资助金额:$1.82万
-
财政年份:2022
-
负责人:Zhang, XuehuaXH
-
依托单位:
Nanobubble-enhanced drag and fouling reduction on lubricant infused surfaces
-
批准号:571752-2021
-
项目类别:Alliance Grants
-
资助金额:$1.82万
-
财政年份:2022
-
负责人:Zhang, XuehuaXH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
槲皮素控释系统调控Mettl3/Per1修复氧化应激损伤促牙周炎骨再生及机制研究
-
批准号:82370921
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:徐袁瑾
-
依托单位:
肿瘤翻译调控蛋白调控大肠癌细胞转移能力的信号机制研究
-
批准号:81000952
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:马强
-
依托单位:
多肽树状物为载体的抗癌前体药物的合成和研究
-
批准号:81072530
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2010
-
负责人:刘河
-
依托单位:
植物病毒壳体"智能"纳米载体靶向肿瘤细胞的研究
-
批准号:30973685
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:曾庆冰
-
依托单位:
高臭氧浓度下水稻颖花和粒重形成受阻及其成因-FACE研究
-
批准号:30871486
-
项目类别:面上项目
-
资助金额:29.0万元
-
批准年份:2008
-
负责人:杨连新
-
依托单位: